BETMIGA cpr ret 50 mg 10 pce
7680627550046
CH-62755
G04BD12
05.02.0.
1 / 3
google
Details
- Product number
- 6275502
- CPT
- -
- Packaging group
- 10
- Unit
- Tablette(n)
- Composition
- mirabegronum 50 mg, E 321, excipiens pro compresso obducto.
Articles (1)
Betmiga 50 mg, Retardtabletten
Tabletten
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
mirabegronum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
macrogolum 2'000'000
|
- | Substance | HNIDK |
|
macrogolum 8000
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
E 321
|
- | Substance | ANTON |
|
magnesii stearas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 8000
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
Authorization holder
Astellas Pharma AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 62755
- Drug name
- Betmiga, Retardtabletten
- Galenic form
- RETT
- ATC Code
- G04BD12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/05/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 05.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BETMIGA cpr ret 50 mg 10 pce
- Description (DE)
- BETMIGA Ret Tabl 50 mg 10 Stk
- Market launch
- 19/05/2014
- Market withdrawal
- 17/07/2019
- Narcotic (BTM)
- No